Company record · updated August 5, 2026
Day One Biopharmaceuticals, Inc: 1 valuation observation from SEC filings
Every row below names the filing it came from. Coverage for this company runs July 31, 2024 to July 31, 2024.
1observations
1source filings
1verified rows
2024-07-31most recent as-of date
Source rails for this company: N-PORT fund mark (1).
Reported by 1 filer: Franklin Small Cap Growth Fund.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2024-07-31 | price per share | 13.8186 USD | Franklin Small Cap Growth Fund | VERIFIED | valUSD 3248760.15 / balance 235100.0 [unspecified] | 000175272424212631 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.